A pilot study of website information regarding aromatase inhibitors: Dietary supplement interactions

Journal of Alternative and Complementary Medicine

Volumn 17, Issue 11, 2011, Pages 1043-1049

  Mcdermott, Cara L ^a   Hsieh, Angela A ^a   Sweet, Erin S ^b   Tippens, Kimberly M ^c   Mccune, Jeannine S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BASTYR UNIVERSITY   (United States)

^c National College of Natural Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; EXEMESTANE; HERBACEOUS AGENT; LETROZOLE; VITAMIN;

ALTERNATIVE MEDICINE; ARTHRALGIA; ARTICLE; BREAST CANCER; DATA BASE; DEPRESSION; DIET SUPPLEMENTATION; EVALUATION; HEADACHE; HEALTH CARE PERSONNEL; HOT FLUSH; HUMAN; INSOMNIA; INTERNATIONAL COOPERATION; INTERNET; MANIPULATIVE MEDICINE; MYALGIA; NAUSEA; OSTEOPOROSIS; PILOT STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; RESIDENT; RISK BENEFIT ANALYSIS;

AROMATASE INHIBITORS; ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; FEMALE; HUMANS; INTERNET; NATUROPATHY; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PILOT PROJECTS; RECEPTORS, ESTROGEN; STUDENTS, PHARMACY;

EID: 81455127618     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2010.0471     Document Type: Article

References (40)

1. McCune JS, Hatfield AJ, Blackburn AA, et al. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 2004;12:454-462. (Pubitemid 38797102)
2. Gupta D, Lis CG, Birdsall TC, Grutsch JF. The use of dietary supplements in a community hospital comprehensive cancer center: Implications for conventional cancer care. Support Care Cancer 2005;13:912-919. (Pubitemid 41502251)
3. Hanigan MH, Dela Cruz BL, Thompson DM, et al. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: Questionnaire validation. J Oncol Pharm Pract 2008;14: 123-130.
4. Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137:889-903. (Pubitemid 35416625)
5. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-2503. (Pubitemid 41115408)
6. Yeung KS, Gubili J. Clinical guide to herb-drug interactions in oncology. J Soc Integr Oncol 2007;5:113-117. (Pubitemid 47555911)
7. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs 2009;69:1777-1798.
8. Werneke U, Earl J, Seydel C, et al. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004;90:408-413. (Pubitemid 38250637)
9. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: A systematic review. J Clin Oncol 2008;26:665-673. (Pubitemid 351264364)
10. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004;22:671-677. (Pubitemid 41095070)
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Breast Cancer. Online document at:www.nccn.org/professionals/physician-gls/f- guidelines.asp Accessed February 2, 2010.
12. Goss PE, Ingle JN, Pater JL, et al. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol 2008;26:1948-1955.
13. Liu B, Edgerton S, Yang X, et al. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res 2005;65:879-886. (Pubitemid 40216447)
14. Calhoun K, Pommier R, Cheek J, et al. The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression. Am J Surg 2003;185:411-415. (Pubitemid 36513948)
15. This P, De La Rochefordiere A, Clough K, et al. Phytoestrogens after breast cancer. Endocr Relat Cancer 2001;8:129-134. (Pubitemid 32641354)
16. Fallowfield L. Quality of life issues in relation to the aromatase inhibitor. J Steroid Biochem Mol Biol 2007;106:168-172. (Pubitemid 47362651)
17. Cella D, Fallowfield LJ. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 2008;107:167-180. (Pubitemid 350265697)
18. Eastell R,Adams JE, Coleman RE, et al. Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 2008;26:1051-1057.
19. Burstein HJ, Winer EP. Aromatase inhibitors and arthralgias: A new frontier in symptom management for breast cancer survivors. J Clin Oncol 2007;25:3797-3799. (Pubitemid 47477251)
20. Astra Zeneca. Arimidex (anastrozole) package insert; 2007.
21. Pfizer. Aromasin (exemestane) package insert; 2008.
22. Novartis. Femara (letrozole) package insert; 2010.
23. Hershman DL. Getting a grip on aromatase inhibitorassociated arthralgias. J Clin Oncol 2008;26:3120-3121.
24. Society for Integrative Oncology. When Taking Herbs, Ask Your Pharmacist about Drug Interactions. Online document at:www.integrativeonc.org/index.php/ when-taking-herbsask-your-pharmacist-about-drug-interactions. Accessed February 2, 2010.
25. Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: Complementary therapies and botanicals. J Soc Integr Oncol 2009;7:85-120.
26. Deng GE, Cassileth BR, Cohen L, et al. Integrative oncology practice guidelines. J Soc Integr Oncol 2007;5:65-84. (Pubitemid 47075456)
27. Charnock D, Shepperd S, Needham G, Gann R. DISCERN: An instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health 1999;53:105-111. (Pubitemid 29043309)
28. Clauson KA, Peak AS, Marsh WA, et al. Clinical decision support tools: Focus on dietary supplement databases. Altern Ther Health Med 2008;14:36-40.
29. Faubert G, Lebel D, Bussieres JF. A pilot study to compare natural health product-drug interactions in two databases in Canada. Pharm World Sci 2010;32:179-186.
30. Boddy K, Ernst E. Review of reliable information sources related to integrative oncology. Hematol Oncol Clin North Am 2008;22:619-630, vii. (Pubitemid 351970208)
31. American Association of Naturopathic Physicians. What is Naturopathic Medicine? Online document at:www .naturopathic.org/ Accessed November 3, 2010.
32. American Association of Naturopathic Physicians. About Naturopathic Medicine. Online document at:http://www.nautropathic.org Accessed November 8, 2010.
33. Brauer JA, El Sehamy A, Metz JM, Mao JJ. Complementary and alternative medicine and supportive care at leading cancer centers: A systematic analysis of websites. J Altern Complement Med 2010;16:183-186.
34. Frenkel M, Gupta A. Nutritional supplements and docetaxel: Avoid or combine? J Soc Integr Oncol 2010;8:120-125.
35. Garrison JA, McCune JS, Livingston RB, et al. Myalgias and arthralgias associated with paclitaxel. Oncology (Williston Park) 2003;17:271-277; discussion 281-272, 286-278.
36. Kuhn J, Prante C, Kleesiek K, Gotting C. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Clin Biochem 2009;42:83-90.
37. Roffe L, Schmidt K, Ernst E. Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: A systematic review. J Clin Oncol 2004;22:4418-4424. (Pubitemid 41185163)
38. Yuvaraj S, Premkumar VG, Shanthi P, et al. Effect of coenzyme Q(10), riboflavin and niacin on tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles. Breast Cancer Res Treat 2009; 114:377-384.
39. Hadji P. Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis. Crit Rev Oncol Hematol 2009;69:73-82.
40. Everett PC. The prevalence of vitamin D deficiency and insufficiency in a hematology-oncology clinic. Clin J Oncol Nurs 2008;12:33-35.